The curative effect of a second curettage in persistent trophoblastic disease: A retrospective cohort survey

Gynecologic Oncology

Volumn 99, Issue 1, 2005, Pages 6-13

  Van Trommel, Nienke E ^a   Massuger, Leon F A G ^a   Verheijen, René H M ^b   Sweep, Fred C G J ^a   Thomas, Chris M G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Human chorionic gonadotropin; Hydatidiform mole; Persistent trophoblastic disease; Second curettage

Indexed keywords

FOLINIC ACID; METHOTREXATE;

ADULT; CANCER CHEMOTHERAPY; CANCER SURGERY; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CURETTAGE; FEMALE; HUMAN; HYDATIDIFORM MOLE; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTER; REOPERATION; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR; UTERUS BLEEDING; UTERUS PERFORATION;

EID: 25144513853     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.06.032     Document Type: Article

References (24)

1. R.C. Bentley Pathology of gestational trophoblastic disease Clin. Obstet. Gynecol. 46 2003 513 522
2. R.S. Berkowitz, and D.P. Goldstein Gestational trophoblastic disease Cancer 76 1995 2079 2085
3. K.D. Bagshawe, S.D. Lawler, F.J. Paradinas, J. Dent, P. Brown, and G.M. Boxer Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole Lancet 335 1990 1074 1076
4. R.S. Berkowitz, D.P. Goldstein, and M.R. Bernstein Natural history of partial molar pregnancy Obstet. Gynecol. 66 1985 677 681
5. S. Goto, A. Yamada, T. Ishizuka, and Y. Tomoda Development of postmolar trophoblastic disease after partial molar pregnancy Gynecol. Oncol. 48 1993 165 170
6. L.W. Rice, R.S. Berkowitz, J.M. Lage, D.P. Goldstein, and M.R. Bernstein Persistent gestational trophoblastic tumor after partial hydatidiform mole Gynecol. Oncol. 36 1990 358 362
7. B.W. Hancock Staging and classification of gestational trophoblastic disease Best Pract. Res., Clin. Obstet. Gynaecol. 17 2003 869 883
8. H.K. Ma, L.C. Wong, and H.Y. Ngan Staging and classification systems B.W. Hancock E.S. Newlands R.S. Berkowitz Gestational trophoblastic disease 1st ed. 1997 Chapman and Hall London 95 108
9. Nederlandse Vereniging voor Obstetrie en Gynaecologie. Molazwangerschap en persisterende trofoblast. http://www nvog nl/files/21_molazwang_persist_trofo pdf ; 1999 [21].
10. FIGO Oncology Committee FIGO staging for gestational trophoblastic neoplasia 2000: FIGO Oncology Committee Int. J. Gynaecol. Obstet. 77 2002 285 287
11. T.Y. Ng, and L.C. Wong Diagnosis and management of gestational trophoblastic neoplasia Best Pract. Res., Clin. Obstet. Gynaecol. 17 2003 893 903
12. R. Osborne, and A. Gerulath What is the best regimen for low-risk gestational trophoblastic neoplasia? A review J. Reprod. Med. 49 2004 602 616
13. J.R. Lurain Advances in management of high-risk gestational trophoblastic tumors J. Reprod. Med. 47 2002 451 459
14. J.T. Soper Role of surgery and radiation therapy in the management of gestational trophoblastic disease Best Pract. Res., Clin. Obstet. Gynaecol. 17 2003 943 957
15. J.B. Schlaerth, C.P. Morrow, and M. Rodriguez Diagnostic and therapeutic curettage in gestational trophoblastic disease Am. J. Obstet. Gynecol. 162 1990 1465 1470
16. M. Pezeshki, B.W. Hancock, P. Silcocks, J.E. Everard, J. Coleman, and A.M. Gillespie The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease Gynecol. Oncol. 95 2004 423 429
17. R.S. Berkowitz, U. Desai, D.P. Goldstein, S.G. Driscoll, A.R. Marean, and M.R. Bernstein Pretreatment curettage-A predictor of chemotherapy response in gestational trophoblastic neoplasia Gynecol. Oncol. 10 1980 39 43
18. F. Flam, and V. Lundstrom The value of endometrial curettage in the follow-up of hydatidiform mole Acta Obstet. Gynecol. Scand. 67 1988 649 651
19. T.T. Lao, F.H. Lee, and S.S. Yeung Repeat curettage after evacuation of hydatidiform mole. An appraisal Acta Obstet. Gynecol. Scand. 66 1987 305 307
20. K.A. Yedema, R.H. Verheijen, P. Kenemans, C.P. Schijf, G.F. Borm, and M.F. Segers Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve Am. J. Obstet. Gynecol. 168 1993 787 792
21. C.M. Thomas, M.F. Segers, and P.C. Houx Comparison of the analytical characteristics and clinical usefulness in tumour monitoring of fifteen hCG(-beta) immunoassay kits Ann. Clin. Biochem. 22 1985 236 246
22. H.Y. Ngan The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia Int. J. Gynecol. Cancer 14 2004 202 205
23. B.W. Hancock, E.M. Welch, A.M. Gillespie, and E.S. Newlands A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease Int. J. Gynecol. Cancer 10 2000 318 322
24. K.D. Bagshawe, J. Dent, and J. Webb Hydatidiform mole in England and Wales 1973-83 Lancet 2 1986 673 677